Evaluation of the Efficacy of Neoadjuvant Radiation Twice a Day Fractionation Therapy in Patients with Resectable Pancreatic Head Cancer

The coronavirus of severe acute respiratory syndrome-2 (SARS-CoV-2) and the coronavirus infection caused by it, along with damage to the respiratory system, can lead to disorders of the central and peripheral nervous system. The article presents literature data and own observations of neurological disorders in patients with coronavirus disease in the superacute period. Pronounced neurological disorders are mainly observed in severe coronavirus disease and include acute ischemic stroke, subcortical micro- and macro— bleeding, acute necrotizing encephalopathy, Guillain-Barre syndrome. Factors potentially complicating the course of coronavirus disease and contributing to the development of neurological complications are hypertension, diabetes mellitus, chronic diseases of the heart and respiratory system. Based on existing publications and our own observations, we have systematized information about the relationship between coronavirus disease and neurological disorders, about possible factors contributing to the occurrence of stroke. The possibilities of using chest MSCT as the only method of radiation diagnostics for the early detection of viral pneumonia in patients receiving emergency and emergency care at the regional vascular center of BUZOO «GC BSMP No. 1» are considered. The use of this method, in the ultra-acute period of acute ischemic stroke, during the first 40 minutes from the moment of admission, can significantly reduce the time of diagnosis and mortality in patients with acute ischemic stroke and viral pneumonia.

1. Granov D. A., Polikarpov A. A., Pavlovskij A. V., Moiseenko V. E., Popov S. A. Evaluation of intra-arterial chemotherapy safety by using of gemcitabine and oxaliplatin in combined treatment of pancreatic head adenocarcinoma. Annals of HPB Surgery. 2017. V. 22. No. 2. P. 54–59 (in Russian).

2. Kaprin A. D. The state of cancer care for the population of Russia in 2020. P. Hertsen MORI. Moscow. 2021. P. 239.

3. Korytova L. I. et al. Possibilities of conformal radiotherapy in the treatment of patients with locally advanced pancreatic cancer. Rossijskij bioterapevticheskij zhurnal. 2017. V. 16. No. s1. P. 44–45 (in Russian).

4. Lushnikov E. F. et al. Therapeutic pathomorphosis of tumors. Pathological diagnosis of human tumors Мoscow: Medicina, 1993. P. 560 (in Russian).

5. Pavlovskij A. V. et al. Influence of perioperative intraarterial selective chemotherapy on terms of recurrent ductal adenocarcinoma of the pancreatic head after pancreaticoduodenectomy. Annals of HPB Surgery. 2018. Т. 23. No. 3. С. 14–22 (in Russian).

6. Bittner M. I. et al. Comparison of toxicity after IMRT and 3D-conformal radiotherapy for patients with pancreatic cancer — a systematic review. Radiotherapy and Oncology. 2015. V. 114. No. 1. P. 117–121.

7. Cloyd J. M. et al. Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: a meta-analysis of randomized controlled trials. J. of Clinical Medicine. 2020. V. 9. No. 4. P. 1129.

8. Coen J. J. et al. Bladder preservation with twice-a-day radiation plus fluorouracil/ cisplatin or once daily radiation plus gemcitabine for muscle-invasive bladder cancer: NRG/RTOG 0712 — a randomized phase II trial. J. of Clinical Oncology. 2019. V. 37. No. 1. P. 44.

9. Gamboa A. C. The role of radiation for pancreatic adenocarcinoma. J. of Pancreatology. 2020. V. 3. No. 2. P. 72–80.

10. Hall W. A., Paulson E. S., van der Heide U. A. et al. The transformation of radiation oncology using real-time magnetic resonance guidance: A review. European J. of Cancer. 2019. V. 122. P. 42–52.

11. Han D. et al. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study. BMC cancer. 2021. V. 21. No. 1. P. 1–11.

12. Pan L. et al. Survival benefits of neoadjuvant chemo (radio) therapy versus surgery first in patients with resectable or borderline resectable pancreatic cancer: a systematic review and meta-analysis. World J. of Surgical Oncology. 2020. V. 18. No. 1. P. 1–13.

13. Qiu B. et al. Transcatheter arterial infusion for pancreatic cancer: a 10-year National Cancer Center experience in 115 patients and literature review. Abdominal Radiology. 2019. V. 44. No. 8. P. 2801–2808.

14. Seshacharyulu P. et al. Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2017. V. 1868. No. 1. P. 69–92.

15. Siegel R. L., Miller K. D., Jemal A. Cancer statistics, 2019. CA: a cancer J. for Clinicians. 2019. V. 69. No. 1. P. 7–34.

16. Versteijne E. et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial. J. of Clinical Oncology. 2020. V. 38. No. 16. P. 1763.

17. Yan M. et al. A Comparison of Hypofractionated and Twice-Daily Thoracic Irradiation in Limited-Stage Small-Cell Lung Cancer: An Overlap-Weighted Analysis. Cancers. 2021. V. 13. No. 12. P. 2895.